| Name | Fumonisin B2-13C34 solution |
|---|
| Description | Fumonisin B2-13C34 is the 13C labeled Fumonisin B2 (HY-N6723)[1]. Fumonisin B2, a mycotoxin produced by Fusarium moniliforme in various grains, is a potent inhibitor of sphingosine N-acyltransferase (ceramide synthase) and disrupts de novo sphingolipid biosynthesis[2][3]. |
|---|---|
| Related Catalog | |
| Target |
Sphingosine N-acyltransferase[2] |
| In Vitro | 氢、碳和其他元素的稳定重同位素已被纳入药物分子中,主要作为药物开发过程中定量的示踪剂。氘化引起了人们的关注,因为它可能影响药物的药代动力学和代谢谱[1]。 |
| References |
| Molecular Formula | 13C34H59NO14 |
|---|---|
| Flash Point | 2 °C |
| Storage condition | −20°C |
| Symbol |
GHS02, GHS07 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H225-H302-H319 |
| Precautionary Statements | P210-P305 + P351 + P338 |
| Hazard Codes | F,Xn |
| Risk Phrases | 11-20/21/22-36 |
| Safety Phrases | 26-36/37-16 |
| RIDADR | UN 1648 3/PG 2 |